Authors


Abby Lynne Singleton, PharmD

Latest:

Key Takeaways on RSV Vaccination

The panel concludes its discussion by providing key takeaways on the evolving RSV vaccination landscape.


Kimberly Lenz, PharmD

Latest:

Evaluating Proactive Outreach for Prior Authorization Recertifications in Medicaid Patients

Implementing a proactive provider outreach program resulted in significantly more prior authorization recertifications and a reduction in time to submission.


John Mark Kelton, PharmD

Latest:

Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology Practice

Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.


Tashi Chodon, MPH, BSN

Latest:

Community Health Workers’ Critical Role in Trust Building Between the Medical System and Communities of Color

The authors interrogate elements of routine medical practice in New York City to argue for reforms of hospital culture through relational trust-building capabilities of community health workers.


Sarah Linke, PhD, MPH

Latest:

Modeling the Economic Value of Cardiometabolic Virtual-First Care Programs

Using a microsimulation approach, this study modeled the potential multiyear health and economic benefits of participating in cardiometabolic virtual-first care programs.


Christopher Subject, MD

Latest:

Development and Validation of the COVID-19 Hospitalized Patient Deterioration Index

The authors developed and validated an accurate, well-calibrated, easy-to-implement COVID-19 hospitalized patient deterioration index to identify patients at high or low risk of clinical deterioration.


Carlyne M. Averell, MS

Latest:

Real-World Users of Triple Therapy for Asthma in the US

This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.


Phil Sarocco, RPh, MSc

Latest:

Adverse Drug Effects Across Patients With Heart Failure: A Systematic Review

This systematic literature review reports incidence of adverse drug effects associated with guideline-directed medical therapy for patients with heart failure with reduced ejection fraction.


Jason Ouyang, MD, MPH

Latest:

Association of Co-pay Elimination With Medication Adherence and Total Cost

This study evaluated cost and utilization attributed to members enrolled in a health care program with no pharmacy co-pay. Health care savings were identified in addition to medication adherence improvements.


Todd L. Foster, PhD

Latest:

An Outpatient Critical Care Transition Clinic Model Reduces Admissions/Readmissions in Medically Complex Patients

Critical care transition clinic patients with chronic conditions had a 31% reduction in relative risk for inpatient admissions, and the clinic reduced cost by more than $1 million.


Perry N. Halkitis, PhD, MS, MPH | Image Credit: Rutgers School of Public Health
Perry N. Halkitis, PhD, MS, MPH

Latest:

Contributor: A Crisis in Public Health—Addressing the Exodus From Our Essential Workforce

Public health professionals are the backbone of our health system, and their contributions are vital to the well-being of our communities. As a society, we must value their work, provide the support they need, and ensure that public health remains a rewarding and viable career choice.


Paula Bickley

Latest:

Bridging the Gap Between Medical and Pharmacy Benefits

As health care costs rise, especially for patients with complex conditions, a major barrier to access is the disconnect between medical benefits and pharmacy benefits.


Suzanne W. Dixon, MPH, MS, RDN

Latest:

Medication Adherence Star Ratings Measures, Health Care Resource Utilization, and Cost

For patients prescribed diabetes, hypertension, and hyperlipidemia medications, nonadherence to CMS Star Ratings quality measures of medication adherence was associated with increased health care resource utilization and costs.


Lori Timmins, PhD

Latest:

Primary Care Redesign and Care Fragmentation Among Medicare Beneficiaries

This article examines the association between a large-scale primary care redesign—the Comprehensive Primary Care Plus Initiative—and ambulatory care patterns of Medicare beneficiaries with highly fragmented care.


Amy D. Herschell, PhD

Latest:

Increased Likelihood of Psychiatric Readmission With Medicaid Expansion vs Legacy Coverage

Individuals who became eligible for Medicaid through Medicaid expansion have an increased likelihood of psychiatric readmission compared with their legacy-enrolled counterparts.


Erin Hunter

Latest:

Dr Ibrahim Aldoss on the Need for Targeted Therapy for KMT2Ar Acute Leukemias

Ibrahim T. Aldoss, MD, of City of Hope Comprehensive Cancer Center, discusses the potential of revumenib in KMT2A-rearranged (KMT2Ar) acute leukemias, with pivotal results presented at the 65th Annual American Society of Hematology Annual Meeting and Exposition this week.


AJMC Contributor

Latest:

Delandistrogene Moxeparvovec Fails to Meet Primary End Point in Phase 3 Study

Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve function after 52 weeks.


Derek DeLia, PhD

Latest:

Primary Care for New vs Established Medicaid Enrollees

Under Affordable Care Act Medicaid expansion in New Jersey, new and distinct patterns of primary care utilization emerged for new vs established enrollees.


Patrick Racsa, MS

Latest:

Medication Adherence Star Ratings Measures, Health Care Resource Utilization, and Cost

For patients prescribed diabetes, hypertension, and hyperlipidemia medications, nonadherence to CMS Star Ratings quality measures of medication adherence was associated with increased health care resource utilization and costs.


Jodi A. Lewis, MPH, MS

Latest:

Pervasiveness and Clinical Staff Perceptions of HPV Vaccination Feedback

This article used regression analyses to quantify how clinical staff perceive provider feedback to improve human papillomavirus (HPV) vaccination rates and determine the prevalence of such feedback.


Nikolaus G. Oberprieler, PhD, MSc, MBA

Latest:

Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes

This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.


Elizabeth Moisan, MS

Latest:

Telehealth Insights From an Integrated Care System

Experiences from a large, integrated, value-based health system suggest that telehealth can be an effective care delivery approach. Public policies can improve telehealth access and care.


Jeffrey Walter, BA

Latest:

Implementing Multistate Behavioral Health Pay-for-Performance Initiatives in Medicaid Managed Care

The authors describe a pay-for-performance initiative targeting behavioral health providers, which was introduced by a large Medicaid managed care organization across multiple states.


Micaela Laber, MPH, MBA

Latest:

Humira: The First $20 Billion Drug

The authors review a House Oversight Committee investigation report on AbbVie’s practices pertaining to adalimumab (Humira) to shed light on broader pharmaceutical market dynamics hindering a competitive market.


Stacy Courtnay

Latest:

In Evaluating Rheumatoid Arthritis Treatments, Involving Patients Is Key

Stacy Courtnay is the community network chair for the Arthritis Foundation in Atlanta highlights a report that discusses how understanding patient experiences in RA can shift questions researchers ask.


Anna U. Morgan, MD, MSc, MSHP

Latest:

Patient Perspectives on Technology-Based Approaches to Social Needs Screening

Patients are essential stakeholders in designing systems to capture social needs. The authors present key findings from patient interviews regarding social needs screening through technology-based modalities.


Anna Chen, PharmD, MS

Latest:

Budget Impact Analysis of Biosimilar Natalizumab in the US

Projected savings from biosimilar natalizumab were $452,611 over 3 years, driven by decreased drug acquisition costs and a utilization shift from reference to biosimilar natalizumab.


Jen Clair, MS

Latest:

Primary Care Visit Cadence and Hospital Admissions in High-Risk Patients

Patients with congestive heart failure and/or chronic obstructive pulmonary disease who had more quarterly primary care visits had lower rates of hospitalizations during the COVID-19 pandemic.


Laura S. Shields-Zeeman, PhD, MS

Latest:

How Medicare Advantage Plans Use Data for Supplemental Benefits Decision-Making

This article presents findings from interviews conducted with executives from 29 Medicare Advantage plans regarding plan decision-making processes related to new social risk factor–related benefits.


John P. Butler

Latest:

Medicare Payment Rule Threatens Access to Life-Sustaining Kidney Care

The authors call on Congress to reform Medicare reimbursement for dialysis, saying the recent rule puts clinics at risk of closure.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo